Table 1.
Characteristics of lung cancer patients during pandemic of COVID-19.
| Pre-Period of CT (N = 200) | Peri-Period of CT (N = 47) | Period of CT (N = 260) | r/z Value | p | |
|---|---|---|---|---|---|
| Stage | −0.24 | <0.001 | |||
| I | 94 (47.0) | 30 (63.8) | 187 (71.9) | ||
| II | 24 (12.0) | 7 (14.9) | 20 (7.7) | ||
| >II | 82 (41.0) | 10 (21.3) | 53 (20.4) | ||
| Pathological type | −2.17 | 0.030 | |||
| Adenocarcinoma | 135 (75.0) | 40 (87.0) | 202 (83.8) | ||
| Squamous cell carcinoma | 45 (25.0) | 6 (13.0) | 39 (16.2) | ||
| Age (mean ± SD) | 62.0 ± 10.34 | 61.0 ± 8.90 | 62.8 ± 11.61 | 0.05 | 0.234 |
| Gender | −4.24 | <0.001 | |||
| Male | 130 (65.0) | 21 (44.7) | 116 (44.6) | ||
| Female | 70 (35.0) | 26 (55.3) | 144 (55.4) |